Daniel B.
Director, Bioinformatics at AstraZeneca
📍 United Kingdom
Daniel B. is the Director of Bioinformatics at AstraZeneca, where he has progressed through roles of increasing seniority. He specializes in applying bioinformatics to drug discovery and development. He holds a Bachelors degree from Anglia Ruskin University and previously worked at Cambridge Epigenetix.
He is actively involved in recruitment for the Joint AstraZeneca-Cancer Research Horizon Functional Genomics Centre (FGC), highlighting his role in a key research collaboration.
Read the full overview →Experience
24 Years
Current Role
Director, Bioinformatics
Job Level
Mid-senior
Location
United Kingdom
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities
Topics Daniel cares about
Functional Genomics
He is directly involved with the Joint AstraZeneca-Cancer Research Horizon Functional Genomics Centre, a major focus of his recent professional activity.
Bioinformatics Leadership
His career path shows a clear progression from scientist roles to a Director position at a major pharmaceutical company, indicating a focus on team and strategy leadership.
Career
Work history
7-2024
Director, Bioinformatics
AstraZeneca
2-2022
Associate Director
AstraZeneca
5-2020 - 3-2022
Senior Bioinformatics Scientist
AstraZeneca
2-2018 - 5-2020
Bioinformatics Scientist
Cambridge Epigenetix
3-2015 - 1-2018
Bioinformatics Consultant - Platform Specialist
Eagle Genomics Ltd.
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Education
1998 - 2001
Bachelor's degree
Anglia Ruskin University
1985 - 1990
Education details unavailable
The Perse School, Hills Road, Cambridge
Social presence
Other AstraZeneca Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.